We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$3.08B
AUM Growth
-$140M
Cap. Flow
-$126M
Cap. Flow %
-4.09%
Top 10 Hldgs %
17.74%
Holding
359
New
43
Increased
87
Reduced
76
Closed
55

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$30.4M
2
BRO icon
Brown & Brown
BRO
+$27.5M
3
XYL icon
Xylem
XYL
+$23.9M
4
AMG icon
Affiliated Managers Group
AMG
+$23.4M
5
SBAC icon
SBA Communications
SBAC
+$22.1M

Sector Composition

Rank Sector Weight
1 Industrials 22.38%
2 Technology 17.8%
3 Consumer Discretionary 15.84%
4 Healthcare 11.15%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
276
Ultragenyx Pharmaceutical
RARE
$2.55B
$273K 0.01%
+5,586
New +$288K
EPM icon
277
Evolution Petroleum
EPM
$131M
$272K 0.01%
21,350
+9,149
+75% +$117K
EW icon
278
CALL
Edwards Lifesciences
EW
$51.7B
$253K 0.01%
20,400
COR icon
279
CALL
Cencora
COR
$61.2B
$249K 0.01%
3,800
KO icon
280
Coca-Cola
KO
$375B
$243K 0.01%
6,286
BCR
281
CALL
DELISTED
CR Bard Inc.
BCR
$222K 0.01%
1,500
BMRN icon
282
CALL
BioMarin Pharmaceuticals
BMRN
$12.4B
$218K 0.01%
3,200
+200
+7% +$14.7K
HTLD icon
283
Heartland Express
HTLD
$956M
$215K 0.01%
9,479
-1,988
-17% -$41.6K
MMSI icon
284
Merit Medical Systems
MMSI
$5.32B
$215K 0.01%
15,023
+2,104
+16% +$31.2K
RENT
285
DELISTED
RENTRAK CORP
RENT
$215K 0.01%
+3,562
New +$204K
NKTR icon
286
Nektar Therapeutics
NKTR
$2.58B
$210K 0.01%
1,153
LPSN icon
287
LivePerson
LPSN
$32.3M
$179K 0.01%
+986
New +$197K
RGEN icon
288
Repligen
RGEN
$9.25B
$178K 0.01%
13,810
-1,778
-11% -$25.5K
CALD
289
DELISTED
Callidus Software, Inc.
CALD
$171K 0.01%
+13,658
New +$180K
CECO icon
290
Ceco Environmental
CECO
$4.14B
$170K 0.01%
10,263
-582
-5% -$9.57K
EXA
291
DELISTED
EXA Corporation
EXA
$158K 0.01%
+11,931
New +$169K
RLD
292
DELISTED
REALD INC COM STK
RLD
$153K 0.01%
13,724
+2,055
+18% +$20.5K
NPKI
293
NPK International
NPKI
$1.14B
$148K ﹤0.01%
12,920
+802
+7% +$9.18K
IRWD icon
294
CALL
Ironwood Pharmaceuticals
IRWD
$714M
$147K ﹤0.01%
+14,209
New +$160K
IDXX icon
295
CALL
Idexx Laboratories
IDXX
$46.2B
$146K ﹤0.01%
2,400
PNNT
296
Pennant Park Investment Corp
PNNT
$241M
$145K ﹤0.01%
13,126
+768
+6% +$8.66K
CARB
297
DELISTED
Carbonite Inc
CARB
$144K ﹤0.01%
14,127
+904
+7% +$9.95K
LFCR icon
298
Lifecore Biomedical
LFCR
$190M
$135K ﹤0.01%
12,109
PODD icon
299
CALL
Insulet
PODD
$9.79B
$123K ﹤0.01%
+2,600
New +$115K
GMAN
300
DELISTED
Gordmans Stores, Inc.
GMAN
$80K ﹤0.01%
14,615
+1,252
+9% +$8.5K

Similar funds

ArrowMark Colorado Holdings's Q1 2014 Portfolio in Review

As of Q1 2014, ArrowMark Colorado Holdings held 359 positions worth $3.08B, down 4.4% from $3.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ArrowMark Colorado Holdings withdrew a net $126M in Q1 2014, closing 55 positions and reducing 76 holdings. Its most notable exit was Brown & Brown, an estimated $27.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, ArrowMark Colorado Holdings opened a new position in CHC GROUP LTD SHS NEW (CYM) worth $23M.

  • ArrowMark Colorado Holdings's largest Q1 2014 buy was CHC GROUP LTD SHS NEW (CYM): 103,900 shares worth $23M.
  • ArrowMark Colorado Holdings added most to Wolverine World Wide in Q1 2014, an estimated $19.2M increase.
  • ArrowMark Colorado Holdings's biggest Q1 2014 reduction was Citigroup, cutting an estimated $30.4M.
  • ArrowMark Colorado Holdings fully exited Brown & Brown in Q1 2014, selling an estimated $27.5M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 18% of its $3.08B portfolio in Q1 2014.
  • ArrowMark Colorado Holdings opened 43 new positions and closed 55 in Q1 2014.
  • ArrowMark Colorado Holdings's portfolio value fell 4.4% quarter-over-quarter to $3.08B.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2014, filed 15 May 2014.